Welcome to the New Nuclear Medicine Technologist Section, providing you access to everything you need on the SNMMI website in one place.
The nuclear medicine and molecular imaging technologists are highly specialized healthcare professionals who works closely with the nuclear medicine physician. Some of the technologist’s primary responsibilities are to: Prepare and administer radioactive chemical compounds, known as radiopharmaceuticals and to administer adjunctive medications in order to perform patient imaging procedures using sophisticated instrumentation; Process data and enhance digital images using advanced computer technology; Provide images, data analysis, and patient information to the physician for diagnostic interpretation; and Evaluate new procedures for appropriateness in specific clinical settings and patient populations.
The Society of Nuclear Medicine and Molecular Imaging Technologist Section as part of the SNMMI, is constantly striving to make a difference in the way nuclear medicine and molecular imaging technologists receive academic and continuing education as well as information concerning new procedures, technologies and equipment. Research has been a vital part of SNMMI-TS activities for many years, as has monitoring federal regulation and influencing decisions that affect the practice of nuclear medicine.
In addition to providing discussion forums and publishing journals, newsletters and books, SNMMI-TS also sponsors international meetings and workshops designed to increase the competencies of nuclear medicine practitioners and to promote new scientific advances. The activities of the SNMMI-TS National Council of Representatives, volunteer committee members, and staff focus on improving the quality of care for the patients served by technologists around the world.
SNMMI educational programs are designed to meet the professional development needs of technologists in the field of nuclear medicine and molecular imaging, as well as providing them with continuing education credit opportunities. SNMMI is an ARRT-recognized conitinuing education mechanism (RCEEMs) provider through the Society's Verification Of Involvement in Continuing Education (VOICE) program.
The PET Online Review Workshop is designed to help prepare technologists for the NMTCB's PET Exam. Following the NMTCB's content outline, the workshop offers a comprehensive review of both PET and PET/CT.
The NCT (Nuclear Cardiology Technologist) Online Review Workshop is designed to prepare technologists for the NMTCB's NCT Exam. The course reviews the NMTCB's nuclear cardiology examination content specifications.
Introducing a new member-benefit. Stay on top of the latest trends and advancements in the profession with quarterly technologist-focused webinars—free for SNMMI-TS members.
July 23, 2015 | 3:00pm ET
SNMMI-TS Members: Free
1.0 VOICE Credit Available.
Join Ellie Mantel, CNMT, RT(N), FSNMMI-TS, and Jessica Williams, CNMT, RT(N), FSNMMI-TS, on Thursday, July 30 at 3pm ET for a complimentary webinar: “Current Utilization in the US.” This webinar will discuss the value of the therapies offered today, and the different types of therapies offered across the US (world) and their efficacy. Complimentary registration available for SNMMI-TS Members
The spectrum of responsibilities for a nuclear medicine technologist varies widely across the United States. Practice components presented in this document provide a basis for establishing the areas of knowledge and performance for the nuclear medicine technologist. The nuclear medicine technologist must be in compliance with all federal, state, and institutional guidelines, including proper documentation of initial and continued competency in those practices and activities.
Continuing education is a necessary component in maintaining the skills required to perform all duties and tasks of the nuclear medicine technologist in this ever-evolving field.
The Nuclear Medicine Technologist Scope of Practice and Performance Standards document is intended to set forth the standards in important areas of the nuclear medicine technologist’s responsibilities. It may not cover all areas which may present themselves in actual practice. These standards do not supersede the judgment of the individual nuclear medicine technologist and other healthcare professionals serving the patient in light of all of the facts of the individual case. THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING AND THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING TECHNOLOGIST SECTION DISCLAIM ALL LIABILITY ARISING FROM USE OF THESE DOCUMENTS.
The SNMMI-TS has a robust grants and awards program sponsored in part by the Education and Research Foundation (ERF). The numerous grants and awards offered spam from financial assistance for tuition for advanced degree programs, travel awards to attend the annual meeting, best abstract awards for abstracts presented during the annual meeting, clinical advancement awards and the leadership academy.
Click here to learn more about all of the available SNMMI-TS awards.
The SNMMI-TS has teamed up with the American Registry for Radiologic Technologists (ARRT) to offer new professional developments grants, with the goal of helping you advance your career as a nuclear medicine technologist. The new AART/SNMMI-TS Professional Development Grants are designed to support up to 13 nuclear medicine technologists wishing to pursue additional educational opportunities, including: SNMMI Annual Meeting attendance, live and online educational courses, ARRT certification exams, and degree seeking education.
Thirteen $500 Grants are available (one per chapter).
Learn more and submit your application.
Application deadline: August 1, 2015.
Visit SNMMI's Career Center.
Additional information is now available regarding the ABR/ABNM Task Force proposal: an ABNM response to the June 4 SNMMI letter and answers to frequently asked questions. Please provide your input today!
Results from the randomized intergroup European Organisation for Research and Treatment of Cancer, Lymphoma Study Association and Fondazione Italiana Linfomi H10 trial have demonstrated that early FDG-PET adapted treatment improves outcomes of early FDG-PET-positive patients with stage I/II Hodgkin’s lymphoma (HL).
(MI: Making a Difference)
Overdiagnosis is commonly discussed in areas like breast imaging, where screening is widely conducted and media interest is high. While it’s under the radar for other diseases, it’s a big enough topic in the medical world to warrant a dedicated issue in Academic Radiology.
(MI: Making a Difference)
Dr. Eric Rohren, a national leader in radiology and nuclear medicine, has been named chair of radiology at Baylor College of Medicine. His appointment is effective Oct. 1.